文献速递神经重症神经肿瘤

去骨瓣清创术后即刻钛网颅骨成形术治疗开颅术后手术部位感染及再手术危险因素

Immediate Titanium Mesh Cranioplasty After Debridement and Craniectomy for Postcraniotomy Surgical Site Infections and Risk Factors for Reoperation.
PubMed 文献 · World Neurosurg · 2022-12-14

回顾性分析48例开颅术后手术部位感染患者,均接受清创、骨瓣去除及即刻钛网颅骨成形术。36例(75.0%)感染消退无需二次手术,12例(25.0%)需再手术;伤口愈合危险因素数量增加与再手术风险显著升高相关(P=0.001),既往调强放疗是再手术的显著危险因素(6.5 [1.40-30.31],P=0.002)。

要点

  • 48例中36例(75.0%)感染消退无需再手术,12例(25.0%)需再手术。
  • 再手术者中6例(12.5%)术中发现明显脓液,6例(12.5%)因伤口愈合不良。
  • 伤口愈合危险因素数量增加与再手术风险显著升高相关(P=0.001)。

核心结论

  • 在清创和骨瓣去除时行即刻钛网颅骨成形术是开颅术后骨瓣感染可接受的治疗选择。
  • 具有多个伤口愈合危险因素的患者再手术风险更高。

研究设计与样本

  • 回顾性分析48例开颅术后手术部位感染患者,均接受手术清创、骨瓣去除及即刻钛网颅骨成形术。
  • 主要结局指标为因持续感染或钛网相关伤口愈合并发症而再手术。

主要发现

  • 48例中15例(31.3%)为女性;最常见原发诊断为胶质母细胞瘤(31.3%)、脑膜瘤(18.8%)和血管/创伤(16.7%)。
  • 47.9%有既往颅脑放疗史;36例(75.0%)感染消退无需二次手术。
  • 12例(25.0%)需再手术:6例(12.5%)术中发现明显脓液,6例(12.5%)因伤口愈合不良再手术且无持续感染证据。
  • Cochran Armitage趋势检验显示伤口愈合危险因素数量增加与再手术风险显著升高相关(P=0.001)。
  • 既往单独调强放疗是再手术的显著危险因素(6.5 [1.40-30.31],P=0.002);中位随访时间20.5周。

临床怎么用

  • 作者认为,在清创和骨瓣去除时行即刻钛网颅骨成形术是开颅术后骨瓣感染可接受的治疗选择。
  • 作者指出,具有多个伤口愈合危险因素的患者再手术风险更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We previously published a novel strategy for management of postcraniotomy bone flap infection consisting of single stage debridement, bone flap removal, and immediate titanium mesh cranioplasty. METHODS: Postcraniotomy patients with surgical site infections treated with surgical debridement, bone flap removal, and immediate titanium mesh cranioplasty were retrospectively reviewed. The primary outcome measure was reoperation due to persistent infection or wound healing complications from the titanium mesh. RESULTS: We included 48 patients, of which 15 (31.3%) were female. The most common primary diagnoses were glioblastoma (31.3%), meningioma (18.8%), and vascular/trauma (16.7%). Most patients had a history of same-site craniotomy prior to the surgery complicated by surgical site infection and 47.9% had prior cranial radiation. Thirty-six (75.0%) patients achieved resolution of their infection and did not require a second operation. Twelve (25.0%) patients required reoperation: 6 (12.5%) patients were found to have frank intraoperative purulence on reoperation, whereas 6 (12.5%) had reoperation for poor wound healing without any evidence of persistent infection. Cochran Armitage trend test revealed that patients with increasing number of wound healing risk factors had significantly higher risk of reoperation (P = 0.001). Prior intensity modulated radiotherapy alone was a significant risk factor for reoperation (6.5 [1.40-30.31], P = 0.002). Median follow-up time was 20.5 weeks. CONCLUSIONS: Immediate titanium mesh cranioplasty at the time of debridement and bone flap removal is an acceptable option in the management of post-craniotomy bone flap infection. Patients with multiple wound healing risk factors are at higher risk for reoperation.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Potter T, Murayi R, Ahorukomeye P, et al. Immediate Titanium Mesh Cranioplasty After Debridement and Craniectomy for Postcraniotomy Surgical Site Infections and Risk Factors for Reoperation. World Neurosurg. 2022. PMID: 36526227. doi:10.1016/j.wneu.2022.12.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。